Mar.14,2019 Ph.D candidate Shangze Gao is awarded The Outstanding Oral Presentation Award at The 92nd Annual Meeting of The Japanese Pharmacological Society.
Mar.1,2019 Dr.kuroda and Dr.Wake are awarded the Excellent Paper Award at The 46th Annual Meeting of the Japanese Society of Intensive Care Medicine.
Jan.10,2019 Prof. Nishibori presents at 47th Myanmar Health Research Congress (Myanmar): “Novel understanding of sepsis pathophysiology and a supplementary therapy with histidine-rich glycoprotein”. NEW
Jan.6,2019 Alumni Association and the Department of Pharmacology Okayama University Medical School's new year party.
Nov.24,2018 Prof. Nishibori presents at The 30th Annual Meeting of the Kidney and Free Radical Research Association: “A proposal of early diagnosis and treatment of sepsis based on pathological analysis of the blood-vascular endothelial cell interface” (invited lecture). NEW
Nov.24,2018 Prof. Nishibori presents at The 28th Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences: “Novel understanding of and development of treatment for sepsis”(invited lecture). NEW
Nov.23,2018 Ms. Nakada joins the Pharmacology Lab.
Oct.2018 Dr. Muraoka joins the Pharmacology Lab.
Oct.2018 O-NECUS exchange student, Ko Bunkan, starts researching in the Pharmacology Lab.
Aug.2018 Ph.D. candidate Terao's study "Histidine-rich glycoprotein suppresses hyperinflammatory responses of lung in a severe acute pancreatitis mouse model" is accepted for publication by the journal "Pancreas".
Aug.2018 Collaboration study with Brown University: "Inter-α inhibitor proteins maintain neutrophils in a resting state by regulating shape and reducing ROS production" is accepted for publication by the journal "Blood Advances" and the press release is completed.
Jun.2, 2018 Dr. Wake and Dr. Fu obtain "The2017 Incentive Award of the Okayama Medical
Association ".
May.2018 Dr. Wake obtains the "TOBIRA Award ".
May.2018 Ms. Maeda (Helsinki Univ.), Mr. Kanemori, and Mr. Hisatsugu (Pharmacology Lab) start their internships.
Mar.6,2018 Dr. Shin joins the Pharmacology Lab.
Jan.22,2018 Japan Blood Products Organization Chitose Plant tour and meet with Prof. Nishibori and
Dr. Wake.
Jan.7,2018 Alumni Association and the Department of Pharmacology Okayama University Medical School's new year party.
Dec.16,2017 The 28th Drug Discovery and Pharmacology Forum is hosted in Okayama.
Dec.10,2017 Global Science Campus in Okayama, Medical Basic Course, Prof.Nishibori.
Dec.9,2017 Western Japan Medical Students Academic Forum 2017.
Dec.2-16,2017 Foreign visiting researcher, Ni Wayan Sucindra Dewi, from Udayana University (Indonesia) participates in a short training course in pharmacology.
Nov.21,2017 AMED ACT-M Site visit.
Nov.6-7,2017 Prof. Nishibori and Dr. Wake attend the 8th International DAMPs and Alarmins Symposium.
Nov.3,2017 Prof. Nishibori lecture at Brown Univ. "Novel understanding of pathophysiological cascade of sepsis: a proposal for the treatment."
Nov.2017 Ph.D candidate Gao's study "Phagocytosis of advanced glycation end products (AGEs) in macrophages induces cell apoptosis" is accepted for publication by the journal "Oxidative Medicine and Cellular Longevity".
Nov.2017 Ph.D candidate, Zhong's study "Effects of histidine-rich glycoprotein on erythrocyte aggregation and hemolysis: implications for a role under septic conditions" is accepted for publication by the journal "Journal of Pharmacological Sciences".
Nov.2017 Ph.D candidate, Kuroda's study "Decrease in histidine-rich glycoprotein as a novel biomarker to predict sepsis among systemic inflammatory response syndrome" is for publication accepted by the journal "Critical Care Medicine".
Oct.2,2017 O-NECUS exchange students Chen Fang, Qiao Handong and Jiang Fan start researching in the Pharmacology Lab.
Oct.2017 Dr. Wang is promoted Assistant Professor.
Oct.2017 Prof. Nishibori obtains a grant of Acceleration Transformative Research for Medical innovation from the Japan Agency for Medical Research and Development. "A drug development using purified HRG from human blood for the treatment of sepsis"
Sep.11-13,2017 Prof. Nishibori lectures at the International Sepsis Forum2017: "Histidine-rich glycoprotein protects vascular endothelial cells and red blood cells in sepsis" (Institut Pasteur, Paris, France)
Sep.2017 Dr. Wake is promoted to Senior Assistant Professor.
Jul.7,2017 Prof. Nishibori attends the International Seminar and Workshop on Advanced Cellular and Molecular Biology Techniques (Udayana Univ., Bali, Indonesia)and presents a lecture on:"Novel understanding of cellular and molecular basis of sepsis pathophysiology: a proposal of new treatment strategy" (invited lecture).
May.2017 Ms. Gao receives a scholarship from the Chinese Government Graduate Student Overseas Study Program.
May.2017 Ms. Iwamoto (Brown Univ.), Ms. Kubo (Helsinki Univ.), Mr. Ano, Mr. Abe, Ms. Hanaya, Ms. Han (Pharmacology Lab) start their research internships.
Apr.10,2017 Dr. Wang's study "Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats" is accepted for publication by the journal "Scientific Reports".
Apr. 2017 Dr. Wake obtains a Grant-in-Aid for Young Scientists (B) from JSPS KAKENHI for the project entitled "Elucidation of an inhibitory mechanism of septic immunothrombosis by novel plasma factor: HRG".
Mar.31,2017 Myanmar Medical Reinforcement project Basic Long-Term Trainee Study Progress Report meeting.
Mar.27,2017 Dr. Fu's study "Therapeutic effects of anti-HMGB1monoclonal antibody on pilocarpine-induced status epilepticus in mice." is accepted for publication by the journal "Scientific Reports".
Mar.10,2017 Prof. Nishibori presents at the 35th Cytoprotection Seminar: "New understanding of sepsis pathology and development of therapy using plasma protein Histidine rich glycoprotein (HRG)" (invited lecture).
Mar.7,2017 Prof. Nishibori presents at the Technical Information Institute Seminar: "Therapeutic effect of anti-HMGB1 antibody on neuropathic pain" (invited lecture).
Feb.23,2017 Zhong, MD, is awarded the 2017 Japan Rotary Yoneyama Scholarship.
Oct.31,2016 Dr. Haruma's study "Anti-high mobility group box-1 (HMGB1) antibody attenuates delayed cerebral vasospasm and brain injury after subarachnoid hemorrhage in rats" is accepted for publication by the journal "Scientific Reports".
Oct.20,2016 O-NECUS exchange students Yi Yue and Hu Dandan start researching in the Pharmacology Lab.
Jun.17,2016 Wang et al. are presented with "An Excellent Presentation Award" at the 37th Annual Meeting of the Japanese Society of Inflammation and Regeneration.
Jun.17,2016 Wake et al.'s study entitled "Histidine-Rich Glycoprotein Prevents Septic Lethality through Regulation of Immunothrombosis and Inflammation" is published in EBioMedicine.
University Press and Japan Agency for Medical & Development simultaneously publish press releases on this work.
Apr. 2016 Dr. Yoshii, Mr. Takahashi and Ms. Gao commence their Doctorate Degrees.
Apr. 2016 Dr. Liu obtains a Grant-in-Aid for Scientific Research (C) from MEXT for the project entitled "Investigation on the effects of anti-HMGB1 mAb on hemorrhagic stroke".
Apr. 2016 Dr. Teshigawara obtains a Grant-in-Aid for Scientific Research (C) from MEXT for the project entitled "Regulation mechanism for expression of HRG in the liver".
Feb. 2016 Ph. D. candidate Izushi's study entitled "Soluble form of the receptor for advanced glycation end-products attenuates inflammatory pathogenesis in a rat model of lipopolysaccharide-induced lung injury" is accepted for publication in J Pharmacol Sci.
Feb.26,2016 Dr. Okuma wins the "3rd Hirakawa Award" at the Japan Society of Neurotraumatology: Award winning paper.
Feb.26,2016 Prof. Nishibori receives approval to transition from the preliminary phase of his Secom Science and Technology Foundation grant to full-scale research.
Feb.21-24,2016 Dr. Kuroda wins the "Research Snapshot Award" at the SCCM 45th Critical Care Congress.
Nov.26-29, 2015 Prof. Nishibori visits the Univ. of Medicine 1 and 2 in Yangon, Myanmar, and lectures on "Sepsis Pathophysiology and its Novel Treatment".
Oct. 2015 Foreign students I Made Winarsa Ruma(Indonesia) and Gao Shange (China) start researching at the Pharmacology Lab.
Oct.23,2015 Prof. Nishibori lectures at The 2nd Kobe Surgery and Blood Apheresis Conference on "Therapeutic strategy and understanding of sepsis and multiple organ failure" (invited lecture).
Sep.26,2015 Prof.Nishibori gives a special lecture at Kinki University Graduate School of Pharmacy on "Therapeutic strategy for sepsis and multiple organ failure".
Sep.12,2015 Prof. Nishibori lectures at the 25th Cerebrovascular Symposium(Senri Life Science Center, Osaka)on stroke treatment targeting HMGB1 (invited lecture).
Sep.10-12,2015 Ph.D. candidates Fu and Wang present their research results at the 7th International DAMPS and HMGB1 Symposium(Bonn, Germany).
Jul.10,2015 "Anti-HMGB1 antibody therapy" is adopted as SEADS B in Translational Research Network Program.
Jun.29,2015 Prof. Nishibori gives a special lecture at Tsinghua University (China).
Apr.15,2015 Dr. Nosaka (Collaborator, Dept. of Pediatrics) is awarded the "ASPR2015 Best Research Award".
Apr.1, 2015 A previous grant awarded by AMED (selected by the Ministry of Health, Labour and Welfare) is approved for continuation.
Apr. 2015 Dr. Soe Soe (Myanmer) and Dr. Nishimura (ART) commence their Doctorate Degrees.
Mar.24,2015 Prof. Nishibori is awarded a grant from the Honjo International Scholarship Foundation.
Mar.4,2015 Ms. Wang, m.Sc., is awarded the International Exchange Award from the Okayama Rotary Club International Exchange Promotion Fund.
Feb.27,2015 Prof. Nishibori is awarded a grant from the Secom Science and Technology Foundation.
Jan. 5, 2015 Created.